Ahmed S. Elserafy

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

2025 Egyptian guidelines for the management of dyslipidemia.

2025 Egyptian guidelines for the management of dyslipidemia.

Journal: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
Published: September 17, 2025

Blood Pressure Variability (BPV): What Clinicians Need to Know a 2025 Expert Consensus Report Endorsed by the Egyptian Society of Cardiology.

Blood Pressure Variability (BPV): What Clinicians Need to Know a 2025 Expert Consensus Report Endorsed by the Egyptian Society of Cardiology.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: June 04, 2025

The Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) Perspectives on the Usage of Inclisiran.

The Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) Perspectives on the Usage of Inclisiran.

Journal: Cardiology and therapy
Published: July 11, 2022

Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction.

Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction.

Journal: Clinical drug investigation
Published: October 17, 2021

Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

Journal: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
Published: February 19, 2020

Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach.

Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach.

Journal: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
Published: February 14, 2018

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography.

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography.

Journal: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
Published: July 31, 2017

The Bermuda triangle: Chronic kidney disease, contrast-induced nephropathy, and atrial fibrillation.

The Bermuda triangle: Chronic kidney disease, contrast-induced nephropathy, and atrial fibrillation.

Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: July 22, 2017

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Journal: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
Published: November 30, 2016
Showing 1-9 of 9

Last Updated: 09/26/2026